Cargando…
Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel
Interest in genomic testing for the selection of cancer therapy is growing. However, the cost of genomic testing has not been well studied. We sought to determine the price of identifying mutations and copy number alterations (CNAs) in theoretically actionable genes across multiple tumor types. We r...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342111/ https://www.ncbi.nlm.nih.gov/pubmed/27634896 http://dx.doi.org/10.18632/oncotarget.11994 |